Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01248091 · ClinicalTrials.gov registry record · NA

The Effect of Nitroprusside on Intrauterine Device (IUD) Insertion

A NA study, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT01248091 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01248091, a NA study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

Increasing accessibility of long-acting reversible contraceptive methods, like intrauterine devices (IUDs), is an important strategy to reduce the risk of unintended pregnancy. Unfortunately, fear of IUD insertion in women who have not had children is common among health care providers and women alike, and this limits IUD use. To increase acceptance of this highly effective contraceptive, there is need to investigate novel, low cost, easily applied and accessible techniques to improve the insertion experience. This is a pilot study to evaluate the efficacy and tolerability of nitroprusside gel applied intracervically as an intervention to improve the IUD insertion experience for both patient and provider.

Interventions

  • PROCEDURE Nitroprusside Gel
  • PROCEDURE Placebo Gel

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2010-12
Est. Completion 2011-07
Phase NA

What the Registry Record Tells You About NCT01248091

The ClinicalTrials.gov registry entry for NCT01248091 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Nitroprusside Gel is the first listed.

NCT01248091 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01248091 about?

NCT01248091 is a clinical study titled "The Effect of Nitroprusside on Intrauterine Device (IUD) Insertion". Increasing accessibility of long-acting reversible contraceptive methods, like intrauterine devices (IUDs), is an important strategy to reduce the risk of unintended pregnancy. Unfortunately, fear of IUD insertion in women who have not had children is common among health care providers and women ali...

What is the current status of trial NCT01248091?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2010-12. Estimated completion is 2011-07.

What interventions are being tested in trial NCT01248091?

The interventions under investigation include: Nitroprusside Gel (PROCEDURE), Placebo Gel (PROCEDURE).

Who is sponsoring clinical trial NCT01248091?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.